AU5161296A - Anti-haemorrhagic peptides - Google Patents

Anti-haemorrhagic peptides

Info

Publication number
AU5161296A
AU5161296A AU51612/96A AU5161296A AU5161296A AU 5161296 A AU5161296 A AU 5161296A AU 51612/96 A AU51612/96 A AU 51612/96A AU 5161296 A AU5161296 A AU 5161296A AU 5161296 A AU5161296 A AU 5161296A
Authority
AU
Australia
Prior art keywords
haemorrhagic
peptides
haemorrhagic peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51612/96A
Inventor
Beatrice Beaubien
Clement E. Burrowes
Zhi-Jie Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allelix Biopharmaceuticals Inc
Original Assignee
Allelix Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allelix Biopharmaceuticals Inc filed Critical Allelix Biopharmaceuticals Inc
Publication of AU5161296A publication Critical patent/AU5161296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
AU51612/96A 1995-04-21 1996-04-19 Anti-haemorrhagic peptides Abandoned AU5161296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42607895A 1995-04-21 1995-04-21
US426078 1995-04-21
PCT/IB1996/000358 WO1996033218A1 (en) 1995-04-21 1996-04-19 Anti-haemorrhagic peptides

Publications (1)

Publication Number Publication Date
AU5161296A true AU5161296A (en) 1996-11-07

Family

ID=23689198

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51612/96A Abandoned AU5161296A (en) 1995-04-21 1996-04-19 Anti-haemorrhagic peptides

Country Status (2)

Country Link
AU (1) AU5161296A (en)
WO (1) WO1996033218A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
SG178780A1 (en) * 2007-02-12 2012-03-29 Biotempt Bv Treatment of trauma-hemorrhage with short oligopeptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277614A (en) * 1985-06-04 1986-12-08 Showa Denko Kk Antiplasmin agent
US5200397A (en) * 1990-02-22 1993-04-06 W. R. Grace & Co.-Conn. Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
EP0478101B1 (en) * 1990-09-24 2001-08-29 W.R. Grace & Co.-Conn. Therapeutic use of peptides having thrombospondin-like activity
WO1992017499A1 (en) * 1991-04-08 1992-10-15 Cornell Research Foundation, Inc. A unique hexapeptide derived from thrombospondin and its uses
CA2063055A1 (en) * 1991-05-22 1992-11-23 Jacob Eyal Peptides having thrombospondin-like activity and their therapeutic use
US5357041A (en) * 1991-12-06 1994-10-18 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin
JPH07503024A (en) * 1992-04-30 1995-03-30 シェリング・コーポレーション Modulation of thrombospondin-CD36 interaction

Also Published As

Publication number Publication date
WO1996033218A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
AU7203496A (en) Novel peptides
AU4780896A (en) Core-board
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU6277796A (en) Urocortin peptides
AU2131195A (en) Prophenins - antibiotic peptides
AU5989696A (en) Tcr vbeta5 peptides
AU4382896A (en) Acetylimidazobenzodiazepines
AU5550296A (en) Conotoxin peptides
AU7520396A (en) Abl-interactor protein
AU5284296A (en) Immune-evading proteins
AU6890696A (en) Peptide derivatives
AU5013796A (en) Wireclamp
AUPM489194A0 (en) Peptides
AU6890596A (en) Peptide derivatives
AU5161296A (en) Anti-haemorrhagic peptides
AU5654096A (en) Antisense peptides
AU5107096A (en) Haemodialyser
AU6153396A (en) E6ap-binding proteins
AU4569496A (en) Tetralinyl- and indanyl-ethylamides
AU5699996A (en) Anti-inflammatory thrombospondin-derived peptides
GB9519511D0 (en) Peptides
AU6476398A (en) Novel peptides